Form D · Other Technology

Cure Forward Corp.

Boston, MA · CIK 0001624526

Offering snapshot reported May 18, 2017 · SEC filing

Reported sold: $4.5M
Investors reported: 1
Minimum accepted: $0
First sale: Dec 16, 2016

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$3,999,997 → $4,499,997

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 18, 2017	Amendment	$4,499,997	$500,000vs Dec 20, 2016	1	SEC filing
Dec 20, 2016	Initial	$3,999,997	No comparison	1	SEC filing
Sep 29, 2016	Initial	$4,325,056	No comparison	1	SEC filing
Jun 22, 2015	Amendment	$4,000,000	$3,500,000vs Nov 14, 2014	1	SEC filing
Jun 22, 2015	Initial	$3,500,000	No comparison	1	SEC filing
Nov 14, 2014	Initial	$500,000	No comparison	1	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-276663

Source: Form D, filed May 18, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Preston Brice	Director
Lauren Farrell	Executive
Seth Harrison	Director
Steve Hau	Executive
Frank Ingari	Director, Executive
Aaron Kantoff	Director
Martin Naley	Director
Stephanie Papes	Director

Issuer details

Industry: Other Technology (See others in industry)

Address:

263 Summer Street 4 Th Floor
Boston, MA, 02210